The year is almost over, and it’s time to make some bold predictions for 2025. In this article, three Motley Fool contributors draw on their experience to forecast what may be in store for the stock market next year. Here’s what they have to say about Artificial Intelligence (AI) software …
Read More »Markets
Rigetti Stock Investors: Here’s What You Need to Know About This Quantum Computing Stock
This quantum computing company is researching innovative solutions to the world’s biggest problems. *Stock prices used were the afternoon prices of Dec. 19, 2024. The video was published on Dec. 21, 2024. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best …
Read More »Here’s How Many Shares of Accenture You Should Own to Get $1,000 in Yearly Dividends
One of the more closely watched stocks in the tech world lately has been consulting company Accenture (NYSE: ACN). That’s because it’s plunging deep into the rapaciously hungry market for artificial intelligence (AI) know-how. Unlike the typical tech (or tech-adjacent) stock, Accenture is a steady, and reliable, dividend payer, handing …
Read More »Will This Artificial Intelligence (AI) Stock Continue Its Meteoric Rise in 2025?
One of the prominent stocks driven by artificial intelligence (AI) is Palantir Technologies (NASDAQ: PLTR). From a low of around $6 per share at the height of the 2022 bear market, the SaaS stock‘s AI tools have driven a more than 12-fold gain in the stock in two years. That …
Read More »Broadcom Is Up Over 25% in the Last Month. Time to Sell?
Broadcom (NASDAQ: AVGO) may have caught many of its bulls by surprise amid its recent surge of 25% after a 40% increase and a significant pullback. The company’s booming AI chip business supercharged a stock that has prospered by building specialty semiconductors. Additionally, acquisitions have proved fortuitous for Broadcom at …
Read More »Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?
Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year’s biotech winners, with the shares climbing 27% from January through a peak in November. The company, the global leader in cystic fibrosis (CF) treatments, has established a long track record of earnings growth thanks to this business …
Read More »Here’s the Average Social Security Benefit at Ages 62, 67, and 70
For more than eight decades, Social Security has been doling out a monthly benefit to retired workers. While this payout isn’t making any of the program’s beneficiaries rich, it has proved to be a necessity, more often than not, for retirees. In each of the last 23 years, Gallup has …
Read More »Is DocuSign an Undervalued Growth Stock to Buy?
DocuSign (NASDAQ: DOCU) will not grow explosively, but slow and steady can still win the race. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » *Stock prices used were the afternoon …
Read More »Is DocuSign an Undervalued Growth Stock to Buy?
DocuSign (NASDAQ: DOCU) will not grow explosively, but slow and steady can still win the race. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » *Stock prices used were the afternoon …
Read More »1 Spectacular AI Stock to Buy Hand Over Fist Before 2025
This business has demonstrated an ability to innovate across several categories. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » *Stock prices used were the afternoon prices of Dec. 19, 2024. The video was published on Dec. 21, 2024. …
Read More »